Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OPRX
OPRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OPRX News
OptimizeRx Shares Rise 5.9% Amid Strong Demand
5d ago
NASDAQ.COM
Three Strong Value Stocks to Consider
Mar 16 2026
NASDAQ.COM
OptimizeRx Shares Decline Amid Market Uncertainty
Mar 06 2026
Benzinga
OptimizeRx Exceeds Q4 2025 Expectations with Strong Financial Results
Mar 06 2026
seekingalpha
OptimizeRx Reports Q4 2025 Earnings Beat with Strong EBITDA Growth
Mar 05 2026
seekingalpha
OptimizeRx Set to Announce Q4 Earnings on March 5
Mar 04 2026
seekingalpha
Whetstone Capital Fully Exits GitLab Holdings
Feb 26 2026
Fool
Whetstone Capital Fully Exits GitLab Position
Feb 26 2026
NASDAQ.COM
Whetstone Capital Fully Exits monday.com Position
Feb 21 2026
Fool
Whetstone Capital Fully Exits monday.com Position
Feb 21 2026
NASDAQ.COM
OptimizeRx Partners with Experian to Enhance DTC Marketing Effectiveness
Jan 07 2026
Globenewswire
OptimizeRx Expands POC Network with Four New Partner Agreements, Increasing NPI Reach by 37%
Dec 17 2025
Globenewswire
OptimizeRx Expands NPI Reach by 37% with Four New Partner Agreements
Dec 17 2025
Newsfilter
Ophirex Secures FDA Agreement for Varespladib Snakebite Treatment Development
Dec 11 2025
Globenewswire
Stephens & Co. Keeps Equal-Weight Rating on OptimizeRx, Reduces Price Target to $17
Nov 17 2025
Benzinga
Top Strong Buy Stocks for November 17: ROKU, AVPT, and Others
Nov 17 2025
NASDAQ.COM
Show More News
